secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adaptive Biotechnologies Corp (ADPT)
CIK:        0001478320
Form:       8-K
Filed at:   2022-03-25T23:59:59+00:00
Accession:  0001564590-22-011827
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Chief Medical Officer Lance Baldo resigns effective March 25, 2022
------------------------------------------------------------------

- Lance Baldo resigned as Chief Medical Officer to pursue a new opportunity.
- Resignation effective March 25, 2022; no replacement named yet.
- Baldo stated no disagreement with the company, management, or board.
- Event reported under Item 8.01 as an other-event disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1478320/000156459022011827/0001564590-22-011827-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1478320/000156459022011827/adpt-8k_20220325.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-011827

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer